Formulation development and in vitro and in vivo evaluation of membrane-moderated transdermal systems of ampicillin sodium in ethanol: PH 4.7 buffer solvent system

AAPS PharmSciTech

Volumn 8, Issue 1, 2007, Pages

  Bagyalakshmi, Janardhanan ^a   Vamsikrishna, Ramachandra Purapu ^a   Manavalan, Rajappan ^b   Ravi, Thengungal Kochupappy ^a   Manna, Probal Kumar ^b  

^a Sri ramakrishna institute of paramedical sciences   (India)

^b ANNAMALAI UNIVERSITY   (India)

Author keywords

Hydrophilic drug; Hydrophilic polymer; In vivo study; Membrane controlled; Swelling ratio

Indexed keywords

ALCOHOL; AMPICILLIN; ANTIINFECTIVE AGENT; DRUG CARRIER; SOLVENT;

ADULT; ARTICLE; ARTIFICIAL MEMBRANE; CHEMISTRY; DIFFUSION; DRUG FORMULATION; DRUG SCREENING; HUMAN; INTRADERMAL DRUG ADMINISTRATION; MALE; MATERIALS TESTING; METHODOLOGY;

ADMINISTRATION, CUTANEOUS; ADULT; AMPICILLIN; ANTI-BACTERIAL AGENTS; DIFFUSION; DRUG CARRIERS; DRUG COMPOUNDING; DRUG EVALUATION, PRECLINICAL; ETHANOL; HUMANS; MALE; MATERIALS TESTING; MEMBRANES, ARTIFICIAL; SOLVENTS;

EID: 84891501536     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/pt0801007     Document Type: Article

References (25)

1. Oliyai R, Lindenbaum S. Stability testing of pharmaceuticals by isothermal heat conduction calorimetry: ampicillin in aqueous solution. Int J Pharm. 1991;73:33-36.
2. Carafa M, Marianecci C, Lucania G, Marchei E, Santucci E. New vesicular ampicillin-loaded delivery systems for topical application: characterization, in vitro permeation experiments and antimicrobial activity. J Control Release. 2004;95:67-74.
3. Ahren IL, Karlsson E, Forsgren A, Riesbeck K. Comparison of the antibacterial activities of ampicillin, ciprofloxacin, clarithromycin, telithromycin, and quinupristin/dalfopistin against intracellular non-typeable Haemophilius influenzae. J Antimicrob Chemother. 2002;50:903-906.
4. Rasheed A, Ravichandran V, Kohli DV. Ampicillin prodrugs: amide conjugates from amino acids, peptide and ampicillin. Pharmazie. 1999;54:857-858.
5. Mandell GL, Douglas RG, Jr, Bennett JE, eds. Principles and Practice of Infectious Diseases. 3rd ed. New York, NY: Churchill Livingstone; 1990:240-242.
6. Acred P, Brown DM, Turner DH, Wilson MJ. Pharmacology and chemotherapy of ampicillin - a new broad-spectrum penicillin. Br J Pharmacol Chemother. 1962;18:356-369.
7. Harmoinen J, Vaali K, Koski P, et al. Enzymatic degradation of a beta-lactam antibiotic, ampicillin, in the gut: a novel treatment modality. J Antimicrob Chemother. 2003;51:361-365.
8. Renke HG, Roos PC, Wells SG. Drug-induced interstitial nephritis with heavy glomerular proteinuria. N Engl J Med. 1980;302:691-692.
9. Linton AL, Clark WF, Driedger AA, Turnbull DI, Lindsay RM. Acute interstitial nephritis due to drugs. Review of the literature with the report of nine cases. Ann Intern Med. 1980;93:735-741.
10. Fontana G, Pitarresi G, Tomarchio V, Carlisi B, San Biagio PL. Preparation, characterization and in vitro antimicrobial activity of ampicillin-loaded polyethylcyanoacrylate nanoparticles. Biomaterials. 1998;19:1009-1017.
11. Schumacher I, Margalit R. Liposome-encapsulated ampicillin: physiochemical and antibacterial properties. J Pharm Sci. 1997;86:635-641.
12. Peng L, Nimni ME. Delivery of erythromycin to subcutaneous tissues in rats by means of a trans-phase delivery system. J Pharm Pharmacol. 1999;51:1135-1141.
13. Martin RA. Anti-infective agents. In: Doerge F, ed. Wilson and Grisvold's Textbook of Organic Medicinal and Pharmaceutical Chemistry. 8th ed. Philadelphia, PA: JB Lippincott; 1991:129-187.
14. Siegel RA. Modeling of drug release from porous polymers. In: Rosoff M, ed. Controlled Release of Drugs, Polymers and Aggregate Systems. New York, NY: VcH Publishers; 1989:46-48.
15. Moffat AC, Osselton MD, Wildop B. Clarke's Isolation and Identification of Drugs. vol. 2. 2nd ed. London, UK: Pharmaceutical Press; 2004:635.
16. Rowe RC, Sheskey PJ, Weller PJ. Handbook of Pharmaceutical Excipients. 4th ed. London, UK: Royal Pharmaceutical Society of Great Britain; 2000:120.
17. Arora P, Mukherjee B. Design, development, physicochemical, and in vitro and in vivo evaluation of transdermal patches containing diclofenac diethylammonium salt. J Pharm Sci. 2002;91: 2076-2089.
18. Baumgartner S, Kristl J, Peppas NA. Network structure of cellulose ethers used in pharmaceutical applications during swelling and at equilibrium. Pharm Res. 2002;19:1084-1090.
19. Vlasses PH, Ribero LGT, Rotmensch HH, et al. Initial evaluation of transdermal timolol serum concentrations and ß-blockade. J Cardiovasc Pharmacol. 1985;7:245-250.
20. Luo W, Catharina A, Harold CT. Rapid method for the determination of ampicillin residues in animal muscle tissue by high-performance liquid chromatography with fluorescence detection. J Chromatogr. 1997;694:401-407.
21. Mehdizadeh A, Toliate T, Rouini RM, Abashzadeh S, Dorkoosh F. Design and in vitro evaluation of new drug-in-adhesive formulations of fentanyl transdermal patches. Acta Pharm. 2004;54:301-317.
22. Fang JY, Sung KC, Lin HH, Fomg CL. Transdermal iontophoretic delivery of diclofenac sodium from various polymer formulations: in vitro and in vivo studies. Int J Pharm. 1999;178:83-92.
23. Krishnaiah YSR, Bhaskar P, Satyanarayana V. Formulation and evaluation of limonene-based membrane-moderated transdermal therapeutic system of nimodipine. Drug Deliv. 2004;11:1-9.
24. USP. US Pharmaceutical National Formulary. vol. USP 27 NF 22. 22nd ed. Rockville, MD: USP; 2003:140.
25. Sulochana KN, Bhooma V, Madhavan HN, Ramakrishnan S, Biswas A. HPLC method for simultaneous determination of ampicillin and sulbactam in biological samples glycerol. Int J Pharm. 1995;27: 189-192.